chr21-34449436-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PM5PP3_ModerateBS2

The NM_000219.6(KCNE1):​c.199C>A​(p.Arg67Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000301 in 1,394,594 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R67P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000015 ( 0 hom., cov: 17)
Exomes 𝑓: 0.000030 ( 2 hom. )
Failed GnomAD Quality Control

Consequence

KCNE1
NM_000219.6 missense

Scores

10
7
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 6.70

Publications

15 publications found
Variant links:
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
KCNE1 Gene-Disease associations (from GenCC):
  • long QT syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Jervell and Lange-Nielsen syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr21-34449436-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 132660.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.928
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE1NM_000219.6 linkc.199C>A p.Arg67Ser missense_variant Exon 4 of 4 ENST00000399286.3 NP_000210.2 P15382C7S316Q6FHJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE1ENST00000399286.3 linkc.199C>A p.Arg67Ser missense_variant Exon 4 of 4 1 NM_000219.6 ENSP00000382226.2 P15382

Frequencies

GnomAD3 genomes
AF:
0.0000150
AC:
2
AN:
133706
Hom.:
0
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.0000278
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000163
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000796
AC:
2
AN:
251382
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000301
AC:
42
AN:
1394594
Hom.:
2
Cov.:
26
AF XY:
0.0000258
AC XY:
18
AN XY:
696710
show subpopulations
African (AFR)
AF:
0.0000309
AC:
1
AN:
32316
American (AMR)
AF:
0.00
AC:
0
AN:
44214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25516
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39290
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84522
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53074
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5652
European-Non Finnish (NFE)
AF:
0.0000371
AC:
39
AN:
1051786
Other (OTH)
AF:
0.0000344
AC:
2
AN:
58224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000150
AC:
2
AN:
133706
Hom.:
0
Cov.:
17
AF XY:
0.0000155
AC XY:
1
AN XY:
64538
show subpopulations
African (AFR)
AF:
0.0000278
AC:
1
AN:
35950
American (AMR)
AF:
0.00
AC:
0
AN:
13180
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4276
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3912
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9296
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.0000163
AC:
1
AN:
61184
Other (OTH)
AF:
0.00
AC:
0
AN:
1754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome 5;C2676723:Jervell and Lange-Nielsen syndrome 2 Uncertain:1
Sep 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Nov 21, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -

Long QT syndrome Uncertain:1
Mar 29, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 67 of the KCNE1 protein (p.Arg67Ser). This variant is present in population databases (rs199473645, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with KCNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1193618). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant disrupts the p.Arg67 amino acid residue in KCNE1. Other variant(s) that disrupt this residue have been observed in individuals with KCNE1-related conditions (PMID: 31941373), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Apr 09, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R67S variant (also known as c.199C>A), located in coding exon 1 of the KCNE1 gene, results from a C to A substitution at nucleotide position 199. The arginine at codon 67 is replaced by serine, an amino acid with dissimilar properties. This variant has been reported in a long QT syndrome (LQTS) cohort (Garmany R et al. Heart Rhythm, 2020 Jun;17:937-944). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.46
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
D;D;D;D;D;D;D;D
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
.;.;T;.;.;.;.;.
M_CAP
Uncertain
0.23
D
MetaRNN
Pathogenic
0.93
D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.8
M;M;M;M;M;M;M;M
PhyloP100
6.7
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-4.1
D;.;.;D;D;D;D;D
REVEL
Pathogenic
0.94
Sift
Uncertain
0.0020
D;.;.;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D;D
Vest4
0.90
MutPred
0.75
Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);Gain of disorder (P = 0.0377);
MVP
0.98
MPC
0.46
ClinPred
0.99
D
GERP RS
5.2
Varity_R
0.47
gMVP
0.90
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199473645; hg19: chr21-35821734; API